# What Are Terpenes in Cannabis? > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/what-are-terpenes-in-cannabis/ > **Published:** 2026-06-17T12:12:26-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:52:09-04:00 > **Clinical Summary:** Evidence-based guide to cannabis terpenes, myrcene, and their clinical effects. What the science shows and doesn't show. --- ✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyTHCCBDHempIndustryDosing Why This Matters Clinicians should understand that terpenes are the aromatic compounds responsible for cannabis’s therapeutic and adverse effects, as they modulate cannabinoid activity through the [entourage effect](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) and influence patient outcomes beyond THC and CBD alone. Patients seeking cannabis for symptom management need guidance on how different terpene profiles affect their individual responses, as myrcene and other terpenes can alter efficacy and side effect profiles. This knowledge enables clinicians to help patients select cannabis products with appropriate terpene combinations for their specific conditions and tolerance levels, moving beyond a one-size-fits-all approach to [cannabinoid therapy](https://cedclinic.com/unknown-cannabinoid-receptor-brain-damage-relief/). Clinical Summary [Cannabis terpenes](https://cedclinic.com/s-caryophyllene-a-terpine-found-in-cannabis-demonstrates-therapeutic-potential-in-a-mouse-model-of-ms/) are aromatic compounds that contribute to the plant’s smell and may influence its pharmacological effects, with myrcene being the most abundant terpene across cannabis varieties. Beyond myrcene, cannabis contains dozens of other terpenes such as limonene, pinene, and linalool, each with distinct sensory profiles and potentially different therapeutic properties including anti-inflammatory, anxiolytic, and analgesic effects. While cannabinoids like THC and CBD have been extensively studied, the clinical significance of individual terpenes and their synergistic interactions with cannabinoids remains incompletely understood, though some evidence suggests terpenes may modulate cannabinoid effects through the “entourage effect.” Current cannabis product labeling and testing standards vary widely by jurisdiction, making it difficult for clinicians to reliably counsel patients on terpene profiles or predict clinical outcomes based on product composition. Understanding terpene profiles may help patients and clinicians select cannabis products more strategically, though robust [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) directly linking specific terpenes to [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) remain limited. Clinicians should recognize that terpene content is an emerging consideration in cannabis product selection, but evidence-based guidance on clinical significance is still developing and should not replace counseling on established cannabis risks and benefits. Dr. Caplan’s Take “Terpenes like myrcene are interesting from a biochemical standpoint and appear in cannabis at meaningful concentrations, but I want to be clear with patients that we still lack robust [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) demonstrating specific therapeutic effects tied to individual terpene profiles in humans. The aromatic and pharmacological properties are real, but claims about which terpene does what remain largely preliminary until we have peer-reviewed evidence from controlled studies.” Clinical Perspective 💊 Terpenes represent volatile aromatic compounds in cannabis that contribute to its sensory profile and are increasingly claimed to modulate clinical effects, though evidence for specific therapeutic roles remains limited and inconsistent. While myrcene and other prevalent terpenes show promise in preclinical models for anti-inflammatory and analgesic properties, translating these findings to clinical benefit is complicated by variable terpene concentrations across products, the difficulty isolating terpene effects from cannabinoid effects, and the lack of standardized dosing or reproducible formulations in most cannabis products. Patients and providers should recognize that “terpene profiling” is currently a marketing tool often ahead of robust clinical validation, and that the aroma or flavor of a cannabis product is not a reliable predictor of its therapeutic outcome. When counseling patients about cannabis use, clinicians would benefit from focusing discussions on total cannabinoid content, dose, route of administration, and individual 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20What%20Are%20Terpenes%20in%20Cannabis%3F%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D59426)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D59426)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20What%20Are%20Terpenes%20in%20Cannabis%3F%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D59426)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [In the Mix: 32 More Articles — June 17, 2026](https://cedclinic.com/32-cannabis-articles-clinical-relevance-june-17-2026/) - [Federal Science Agency Adds New Cannabis Compounds To Its Library Of ‘Chemical Fingerprints’](https://cedclinic.com/federal-science-agency-adds-new-cannabis-compounds-to-its-library-of-chemical-fingerprints/) - [Cannabis Flower Reimbursement: Bundestag Votes on Insurance Coverage Cuts](https://cedclinic.com/cannabis-flower-reimbursement-bundestag-votes-on-insurance-coverage-cuts/) 📰 Source: [https://gardenclubdispensaries.com/cannabis-blog/what-are-terpenes-why-do-they-matter/](https://gardenclubdispensaries.com/cannabis-blog/what-are-terpenes-why-do-they-matter/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).